These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25216246)

  • 61. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of tyrosinase gene mutations using direct automated infrared fluorescence DNA sequencing of amplified exons.
    Oetting WS; Fryer JP; Oofuji Y; Middendorf LR; Brumbaugh JA; Summers CG; King RA
    Electrophoresis; 1994 Feb; 15(2):159-64. PubMed ID: 8026428
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determination of variants in the 3'-region of the tyrosinase gene requires locus specific amplification.
    Chaki M; Mukhopadhyay A; Ray K
    Hum Mutat; 2005 Jul; 26(1):53-8. PubMed ID: 15895460
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
    Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
    Mondal M; Sengupta M; Ray K
    Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families].
    Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SLC45A2 variations in Indian oculocutaneous albinism patients.
    Sengupta M; Chaki M; Arti N; Ray K
    Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper.
    Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y
    Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism.
    Oetting WS; King RA
    Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular basis of oculocutaneous albinism type 1 in Lebanese patients.
    Zahed L; Zahreddine H; Noureddine B; Rebeiz N; Shakar N; Zalloua P; Haddad F
    J Hum Genet; 2005; 50(6):317-319. PubMed ID: 15937636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1).
    Lee ST; Park SK; Lee H; Lee JS; Park YW
    Jpn J Hum Genet; 1997 Dec; 42(4):499-505. PubMed ID: 9560949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mutations of the tyrosinase gene in oculocutaneous albinism.
    Shibahara S
    Pigment Cell Res; 1992 Nov; 5(5 Pt 2):279-83. PubMed ID: 1292010
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A comprehensive analysis reveals mutational spectra and common alleles in Chinese patients with oculocutaneous albinism.
    Wei A; Wang Y; Long Y; Wang Y; Guo X; Zhou Z; Zhu W; Liu J; Bian X; Lian S; Li W
    J Invest Dermatol; 2010 Mar; 130(3):716-24. PubMed ID: 19865097
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism.
    Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y
    Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutations in the MATP gene in five German patients affected by oculocutaneous albinism type 4.
    Rundshagen U; Zühlke C; Opitz S; Schwinger E; Käsmann-Kellner B
    Hum Mutat; 2004 Feb; 23(2):106-110. PubMed ID: 14722913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.